REG vs TXG · P/E 34, $12.93B cap vs rev $610.8M
Regency Centers Corporation (REG) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
REG does not have a complete income-statement cache yet.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
REG currently screens at market cap $12.93B and trailing P/E 33.5. TXG currently screens at market cap $4.08B.
Not investment advice. Open the REG and TXG stock pages for the full models.
Not investment advice.